Related Experiment Video

Updated: Sep 30, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

An adenovirus vector containing the suicide gene thymidine kinase for a broad application in cancer gene therapy

G S Magalhaes1, A R Muotri, M C N Marchetto

  • 1Departamento de Microbiologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo, SP, 05508-900, Brasil.

Memorias Do Instituto Oswaldo Cruz
|July 16, 2002
PubMed

Insights

Gene therapy for cancer uses suicide genes like herpes simplex virus thymidine kinase (TK) to eliminate tumor cells. This study demonstrates a novel adenovirus vector (Ad-TK) effectively kills cancer cells using TK and ganciclovir, showing promoter flexibility.

Area of Science:

  • Molecular Biology
  • Cancer Gene Therapy
  • Virology

Background:

  • Gene therapy offers a promising approach for cancer treatment by introducing genes that lead to cancer cell elimination.
  • Suicide gene therapy utilizes enzymes to convert pro-drugs into cytotoxic agents, with the herpes simplex virus thymidine kinase (TK) gene and ganciclovir (GCV) being a widely used combination.
  • The efficiency of gene therapy is significantly influenced by the choice of promoter, which dictates transgene expression levels and cell-type specificity.

Purpose of the Study:

  • To construct a recombinant adenovirus carrying the herpes simplex virus thymidine kinase (TK) gene (Ad-TK) driven by three strong promoters: P CMV IE, SV40, and EN1.
  • To evaluate the effectiveness of the Ad-TK vector in killing human HeLa and mouse CCR2 tumor cells.
  • To analyze the transcriptional products of the TK gene from different promoters in various cell types.

Main Methods:

  • Construction of a recombinant adenovirus vector (Ad-TK) expressing the TK gene under the control of P CMV IE, SV40, and EN1 promoters.
  • Transduction of human HeLa and mouse CCR2 tumor cells with the Ad-TK vector.
  • Administration of ganciclovir (GCV) to treated cells to induce cytotoxicity.
  • Analysis of TK gene transcripts using methods to detect different transcript sizes.

Main Results:

  • Successful transduction and efficient killing of both human HeLa and mouse CCR2 tumor cells upon GCV administration.
  • Detection of two distinct TK gene transcript sizes, originating from the P CMV IE/SV40 promoters and the downstream EN1 promoter.
  • Differential expression levels of TK transcripts from the various promoters were observed between the two cell types, indicating promoter flexibility.

Conclusions:

  • The Ad-TK vector system demonstrates significant potential for cancer gene therapy, effectively eliminating tumor cells.
  • The use of multiple strong promoters (P CMV IE, SV40, EN1) provides flexibility in controlling TK gene expression.
  • Cell-type-specific differences in transcript levels highlight the adaptability of this gene therapy approach for diverse tumor environments.

More Related Videos

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors14:55

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors

Published on: December 3, 2013

Related Concept Videos

Gene Therapy01:22

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
In-vitro Mutagenesis (Gene Knockouts)02:29

In-vitro Mutagenesis (Gene Knockouts)

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.